Moreover, NUSAP1 is the only gene that appears in two out of the three commercially available gene expression signatures currently used for assessing aggressive PCa [52, 53] and (Rye et al, unpublished). The gene discussed is NUSAP1; the disease is posterior cortical atrophy.